A House panel approved along party lines a measure that would strengthen the tracking of prescription treatments. The FDA will be required to propose new regulations to protect consumers from counterfeit prescriptions by 2027, but the measure does not require that those rules be put into effect.

Full Story:
Hill, The

Related Summaries